Erratum: Role of sirtuins in chronic obstructive pulmonary disease (Archives of Pharmacal Research (2015) 38 (1-10) (DOI 10.1007/s12272-014-0494-2));Role of sirtuins in chronic obstructive pulmonary disease

Archives of Pharmacal Research

Volumn 38, Issue 1, 2015, Pages 1-10

  Chun, Pusoon ^a  

^a Inje University   (South Korea)

Author keywords

Cigarette smoke; COPD; Oxidative stress; SIRT1; SIRT6; Sirtuins

Indexed keywords

MATRIX METALLOPROTEINASE; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN 3; SIRTUIN 4; SIRTUIN 5; SIRTUIN 6; SIRTUIN 7; ENZYME ACTIVATOR; SIRT1 PROTEIN, HUMAN; SIRT6 PROTEIN, HUMAN;

AUTOPHAGY; CELL AGING; CELL DIFFERENTIATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; LUNG EMPHYSEMA; LUNG FIBROSIS; NONHUMAN; OXIDATION REDUCTION STATE; REVIEW; ANIMAL; BIOLOGICAL MODEL; COMPLICATION; DRUG EFFECTS; ENZYMOLOGY; FIBROSIS; INFLAMMATION; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ANIMALS; AUTOPHAGY; CELL AGING; ENZYME ACTIVATORS; FIBROSIS; HUMANS; INFLAMMATION; LUNG; MODELS, IMMUNOLOGICAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SIRTUIN 1; SIRTUINS;

EID: 84920621954     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-015-0555-1     Document Type: Erratum

References (121)

1. Amsellem, V., G. Gary-Bobo, E. Marcos, B. Maitre, V. Chaar, P. Validire, J.B. Stern, H. Noureddine, E. Sapin, D. Rideau, S. Hue, P. Le Corvoisier, S. Le Gouvello, J.L. Dubois-Randé, J. Boczkowski, and S. Adnot. 2011. Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 184: 1358-1366.
2. Aoshiba, K., F. Zhou, T. Tsuji, and A. Nagai. 2012. DNA damage as a molecular link in the pathogenesis of COPD in smokers. European Respiratory Journal 39: 1368-1376.
3. Araya, J., S. Cambier, J.A. Markovics, P. Wolters, D. Jablons, A. Hill, W. Finkbeiner, K. Jones, V.C. Broaddus, D. Sheppard, A. Barzcak, Y. Xiao, D.J. Erle, and S.L. Nishimura. 2007. Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients. The Journal of clinical investigation 117: 3551-3562.
4. Arunachalam, G., I.K. Sundar, J.W. Hwang, H. Yao, and I. Rahman. 2010. Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: Implications in comorbidities of COPD. Journal of Inflammation (London) 7: 34.
5. Aquilano, K., P. Vigilanza, S. Baldelli, B. Pagliei, G. Rotilio, and M.R. Ciriolo. 2010. Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. Journal of Biological Chemistry 285: 21590-21599.
6. Bao, J., and M.N. Sack. 2010. Protein deacetylation by sirtuins: Delineating a post-translational regulatory program responsive to nutrient and redox stressors. Cellular and Molecular Life Sciences 67: 3073-3087.
7. Bartkova, J., N. Rezaei, M. Liontos, P. Karakaidos, D. Kletsas, N. Issaeva, L.V. Vassiliou, E. Kolettas, K. Niforou, V.C. Zoumpourlis, M. Takaoka, H. Nakagawa, F. Tort, K. Fugger, F. Johansson, M. Sehested, C.L. Andersen, L. Dyrskjot, T. Ørntoft, J. Lukas, C. Kittas, T. Helleday, T.D. Halazonetis, J. Bartek, and V.G. Gorgoulis. 2006. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444: 633-637.
8. Barnes, P.J. 2004. Alveolar macrophages as orchestrators of COPD. COPD 1: 59-70.
9. Blander, G., and L. Guarente. 2004. The Sir2 family of protein deacetylases. Annual Review of Biochemistry 73: 417-435.
10. Bonniaud, P., M. Kolb, T. Galt, J. Robertson, C. Robbins, M. Stampfli, C. Lavery, P.J. Margetts, A.B. Roberts, and J. Gauldie. 2004. Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis. J. Immunol. 173: 2099-2108.
11. Borra, M.T., B.C. Smith, and J.M. Denu. 2005. Mechanism of human SIRT1 activation by resveratrol. Journal of Biological Chemistry 280: 17187-17195.
12. Brooke, B.S., A. Bayes-Genis, and D.Y. Li. 2003. New insights into elastin and vascular disease. Trends in Cardiovascular Medicine 13: 176-181.
13. Caito, S., J.W. Hwang, S. Chung, H. Yao, I.K. Sundar, and I. Rahman. 2010. PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity. Biochemical and Biophysical Research Communications 392: 264-270.
14. Cataldo, D., C. Munaut, A. Noël, F. Frankenne, P. Bartsch, J.M. Foidart, and R. Louis. 2000. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. International Archives of Allergy and Immunology 123: 259-267.
15. Chen, J., Y. Zhou, S. Mueller-Steiner, L.F. Chen, H. Kwon, S. Yi, L. Mucke, and L. Gan. 2005. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. Journal of Biological Chemistry 280: 40364-40374.
16. Chen, Z.H., H.P. Kim, F.C. Sciurba, S.J. Lee, C. Feghali-Bostwick, D.B. Stolz, R. Dhir, R.J. Landreneau, M.J. Schuchert, S.A. Yousem, K. Nakahira, J.M. Pilewski, J.S. Lee, Y. Zhang, S.W. Ryter, and A.M. Choi. 2008. Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 3: e3316.
17. Cheng, H.L., R. Mostoslavsky, S. Saito, J.P. Manis, Y. Gu, P. Patel, R. Bronson, E. Appella, F.W. Alt, and K.F. Chua. 2003. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proceedings of the National Academy of Sciences 100: 10794-10799.
18. + lymphocytes in patients with COPD. Chest 125: 71-76.
19. Costa, C., R. Rufino, S.L. Traves, E. Lapa, J.R. Silva, P.J. Barnes, and L.E. Donnelly. 2008. CXCR3 and CCR5 chemokines in the induced sputum from patients with COPD. Chest 133: 26-33.
20. Churg, A., S. Zhou, and J.L. Wright. 2012. Series matrix metalloproteinases in lung health and disease: Matrix metalloproteinases in COPD. European Respiratory Journal 39: 197-209.
21. de Boer, W.I., A. van Schadewijk, J.K. Sont, H.S. Sharma, J. Stolk, P.S. Hiemstra, and J.H. van Krieken. 1998. Transforming growth factor beta 1 and recruitment of macrophages and mast cells in airways in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 158: 1951-1957.
22. de la Lastra, C.A., and I. Villegas. 2007. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochemical Society Transactions 35: 1156-1160.
23. Deshmane, S.L., S. Kremlev, S. Amini, and B.E. Sawaya. 2009. Monocyte chemoattractant protein-1 (MCP-1): An overview. Journal of Interferon and Cytokine Research 29: 313-326.
24. Di Stefano, A., A. Capelli, M. Lusuardi, P. Balbo, C. Vecchio, P. Maestrelli, C.E. Mapp, L.M. Fabbri, C.F. Donner, and M. Saetta. 1998. Severity of airflow limitation is associated with severity of airway inflammation in smokers. American Journal of Respiratory and Critical Care Medicine 158: 1277-1285.
25. Dioum, E.M., R. Chen, M.S. Alexander, Q. Zhang, R.T. Hogg, R.D. Gerard, and J.A. Garcia. 2009. Regulation of hypoxia-inducible factor 2alpha signaling by the stress-responsive deacetylase sirtuin 1. Science 324: 1289-1293.
26. Du, J., H. Jiang, and H. Lin. 2009. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD. Biochemistry 48: 2878-2890.
27. Du, J., Y. Zhou, X. Su, J.J. Yu, S. Khan, H. Jiang, J. Kim, J. Woo, J.H. Kim, B.H. Choi, B. He, W. Chen, S. Zhang, R.A. Cerione, J. Auwerx, Q. Hao, and H. Lin. 2011. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 334: 806-809.
28. Frye, R.A. 2000. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochemical and Biophysical Research Communications 273: 793-798.
29. + depletion. Cellular Physiology and Biochemistry 20: 45-54.
30. Ganesan, S., A.N. Faris, A.T. Comstock, S.S. Chattoraj, A. Chattoraj, J.R. Burgess, J.L. Curtis, F.J. Martinez, S. Zick, M.B. Hershenson, and U.S. Sajjan. 2010. Quercetin prevents progression of disease in elastase/LPS-exposed mice by negatively regulating MMP expression. Respiratory Research 11: 131.
31. Gorgoulis, V.G., L.V. Vassiliou, P. Karakaidos, P. Zacharatos, A. Kotsinas, T. Liloglou, M. Venere, R.A. Ditullio Jr, N.G. Kastrinakis, B. Levy, D. Kletsas, A. Yoneta, M. Herlyn, C. Kittas, and T.D. Halazonetis. 2005. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434: 907-913.
32. Gorospe, M., and R. de Cabo. 2008. As SIRTing the DNA damage response. Trends in Cell Biology 18: 77-83.
33. Gray, K., and M. Bennett. 2011. Role of DNA damage in atherosclerosis-Bystander or participant? Biochemical Pharmacology 82: 693-700.
34. Guarente, L., and H. Franklin. 2011. Epstein Lecture: Sirtuins, aging, and medicine. New England Journal of Medicine 364: 2235-2244.
35. Gueders, M.M., J.M. Foidart, A. Noel, and D.D. Cataldo. 2006. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. European Journal of Pharmacology 533: 133-144.
36. Hageman, G.J., I. Larik, H.J. Pennings, G.R. Haenen, E.F. Wouters, and A. Bast. 2003. Systemic poly(ADP-ribose) polymerase-1 activation, chronic inflammation, and oxidative stress in COPD patients. Free Radical Biology and Medicine 35: 140-148.
37. +-dependent protein deacetylase. Biochemical Journal 411: e11-e13.
38. Hautamaki, R.D., D.K. Kobayashi, R.M. Senior, and S.D. Shapiro. 1997. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 277: 2002-2004.
39. Hsu, C.P., N. Hariharan, R.R. Alcendor, S. Oka, and J. Sadoshima. 2009. Nicotinamide phosphoribosyltransferase regulates cell survival through autophagy in cardiomyocytes. Autophagy 5: 1229-1231.
40. Huang, Q., Y.T. Wu, H.L. Tan, C.N. Ong, and H.M. Shen. 2009. A novel function of poly(ADP-ribose) polymerase-1 in modulation of autophagy and necrosis under oxidative stress. Cell Death and Differentiation 16: 264-277.
41. Huynh, M.L., V.A. Fadok, and P.M. Henson. 2002. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta 1 secretion and the resolution of inflammation. The Journal of clinical investigation 109: 41-50.
42. Hwang, J.W., S. Chung, I.K. Sundar, H. Yao, G. Arunachalam, M.W. McBurney, and I. Rahman. 2010. Cigarette smoke-induced autophagy is regulated by SIRT1-PARP-1-dependent mechanism: Implication in pathogenesis of COPD. Archives of Biochemistry and Biophysics 500: 203-209.
43. Hwang, J.W., H. Yao, S. Caito, I.K. Sundar, and I. Rahman. 2013. Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radical Biology and Medicine 61: 95-110.
44. Ilumets, H., P. Rytilä, I. Demedts, G.G. Brusselle, A. Sovijärvi, M. Myllärniemi, T. Sorsa, and V.L. Kinnula. 2007. Matrix metalloproteinases -8, -9 and -12 in smokers and patients with stage 0 COPD. International Journal of Chronic Obstructive Pulmonary Disease 2: 369-379.
45. Kim, H.P., X. Wang, Z.H. Chen, S.J. Lee, M.H. Huang, Y. Wang, S.W. Ryter, and A.M. Choi. 2008. Autophagic proteins regulate cigarette smoke-induced apoptosis: Protective role of heme oxygenase-1. Autophagy 4: 887-895.
46. Kim, W., and J.E. Kim. 2013. SIRT7 an emerging sirtuin: Deciphering newer roles. Journal of Physiology and Pharmacology 64: 531-534.
47. Kitagawa, M., S.H. Lee, and F. McCormick. 2008. Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Molecular Cell 29: 217-231.
48. Klionsky, D.J., and S.D. Emr. 2000. Autophagy as a regulated pathway of cellular degradation. Science 290: 1717-1721.
49. Knobloch, J., C. Wahl, M. Feldmann, D. Jungck, J. Strauch, E. Stoelben, and A. Koch. 2014. Resveratrol attenuates the release of inflammatory cytokines from human bronchial smooth muscle cells exposed to lipoteichoic acid in chronic obstructive pulmonary disease. Basic and Clinical Pharmacology and Toxicology 114: 202-209.
50. Kracikova, M., G. Akiri, A. George, R. Sachidanandam, and S.A. Aaronson. 2013. A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death and Differentiation 20: 576-588.
51. Kunsch, C., and R.M. Medford. 1999. Oxidative stress as a regulator of gene expression in the vasculature. Circulation Research 85: 753-766.
52. Kurz, D.J., S. Decary, Y. Hong, E. Trivier, A. Akhmedov, and J.D. Erusalimsky. 2004. Chronic oxidative stress compromises telomere integrity and accelerates the onset of senescence in human endothelial cells. Journal of Cell Science 117: 2417-2426.
53. Landry, J., J.T. Slama, and R. Sternglanz. 2000. Role of NAD(+) in the deacetylase activity of the SIR2-like proteins. Biochemical and Biophysical Research Communications 278: 685-690.
54. Langley, E., M. Pearson, M. Faretta, U.M. Bauer, R.A. Frye, S. Minucci, P.G. Pelicci, and T. Kouzarides. 2002. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO Journal 21: 2383-2396.
55. Lanzillotta, A., I. Sarnico, R. Ingrassia, F. Boroni, C. Branca, M. Benarese, G. Faraco, F. Blasi, A. Chiarugi, P. Spano, and M. Pizzi. 2010. The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. Cell Death and Disease 1: e96.
56. Lin, S.J., P.A. Defossez, and L. Guarente. 2000. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science 289: 2126-2128.
57. Liszt, G., E. Ford, M. Kurtev, and L. Guarente. 2005. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. Journal of Biological Chemistry 280: 21313-21320.
58. Luo, J., A.Y. Nikolaev, S. Imai, D. Chen, F. Su, A. Shiloh, L. Guarente, and W. Gu. 2001. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107: 137-148.
59. Maclay, J.D., D.A. McAllister, R. Rabinovich, I. Haq, S. Maxwell, S. Hartland, M. Connell, J.T. Murchison, E.J. van Beek, R.D. Gray, N.L. Mills, and W. Macnee. 2012. Systemic elastin degradation in chronic obstructive pulmonary disease. Thorax 67: 606-612.
60. MacNee, W. 2001. Oxidative stress and lung inflammation in airways disease. European Journal of Pharmacology 429: 195-207.
61. Majo, J., H. Ghezzo, and M.G. Cosio. 2001. Lymphocyte population and apoptosis in the lungs of smokers and their relation to emphysema. European Respiratory Journal 17: 946-953.
62. Manoury, B., S. Nenan, I. Guénon, V. Lagente, and E. Boichot. 2007. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis. International Immunopharmacology 7: 900-911.
63. McAllister, D.A., J.D. Maclay, N.L. Mills, G. Mair, J. Miller, D. Anderson, D.E. Newby, J.T. Murchison, and W. Macnee. 2007. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 176: 1208-1214.
64. McCord, R.A., E. Michishita, T. Hong, E. Berber, L.D. Boxer, R. Kusumoto, S. Guan, X. Shi, O. Gozani, A.L. Burlingame, V.A. Bohr, and K.F. Chua. 2009. SIRT6 stabilizes DNA-dependent Protein Kinase at chromaitn for DNA double-strnad break repair. Aging 1: 109-121.
65. McDonough, J.E., R. Yuan, M. Suzuki, N. Seyednejad, W.M. Elliott, P.G. Sanchez, A.C. Wright, W.B. Gefter, L. Litzky, H.O. Coxson, P.D. Paré, D.D. Sin, R.A. Pierce, J.C. Woods, A.M. McWilliams, J.R. Mayo, S.C. Lam, J.D. Cooper, and J.C. Hogg. 2011. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. New England Journal of Medicine 365: 1567-1575.
66. Mercer, B.A., N. Kolesnikova, J. Sonett, and J. D'Armiento. 2004. Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. Journal of Biological Chemistry 279: 17690-17696.
67. Minagawa, S., J. Araya, T. Numata, S. Nojiri, H. Hara, Y. Yumino, M. Kawaishi, M. Odaka, T. Morikawa, S.L. Nishimura, K. Nakayama, and K. Kuwano. 2011. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF-β-induced senescence of human bronchial epithelial cells. American Journal of Physiology. Lung Cellular and Molecular Physiology 300: L391-L401.
68. Michan, S., and D. Sinclair. 2007. Sirtuins in mammals: Insights into their biological function. Biochemical Journal 404: 1-13.
69. Michishita, E., J.Y. Park, J.M. Burneskis, J.C. Barrett, and I. Horikawa. 2005. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Molecular Biology of the Cell 16: 4623-4635.
70. Mostoslavsky, R., K.F. Chua, D.B. Lombard, W.W. Pang, M.R. Fischer, L. Gellon, P. Liu, G. Mostoslavsky, S. Franco, M.M. Murphy, K.D. Mills, P. Patel, J.T. Hsu, A.L. Hong, E. Ford, H.L. Cheng, C. Kennedy, N. Nunez, R. Bronson, D. Frendewey, W. Auerbach, D. Valenzuela, M. Karow, M.O. Hottiger, S. Hursting, J.C. Barrett, L. Guarente, R. Mulligan, B. Demple, G.D. Yancopoulos, and F.W. Alt. 2006. Genomic instability and aginglike phenotype in the absence of mammalian SIRT6. Cell 124: 315-329.
71. Murphy, G., and A.J. Docherty. 1992. The matrix metalloproteinases and their inhibitors. American Journal of Respiratory Cell and Molecular Biology 7: 120-125.
72. Nakamaru, Y., C. Vuppusetty, H. Wada, J.C. Milne, M. Ito, C. Rossios, M. Elliot, J. Hogg, S. Kharitonov, H. Goto, J.E. Bemis, P. Elliott, P.J. Barnes, and K. Ito. 2009. A protein deacetylase SIRT1 is a negative regulator of metalloproteinase-9. The FASEB Journal 23: 2810-2819.
73. North, B.J., and E. Verdin. 2007. Interphase nucleocytoplasmic shuttling and localization of SIRT2 during mitosis. PLoS ONE 2: e784.
74. Ogata, M., S. Hino, A. Saito, K. Morikawa, S. Kondo, S. Kanemoto, T. Murakami, M. Taniguchi, I. Tanii, K. Yoshinaga, S. Shiosaka, J.A. Hammarback, F. Urano, and K. Imaizumi. 2006. Autophagy is activated for cell survival after endoplasmic reticulum stress. Molecular and Cellular Biology 26: 9220-9231.
75. Oit-Wiscombe, I., L. Virag, U. Soomets, and A. Altraja. 2013. Increased DNA damage in progression of COPD: a response by poly(ADP-ribose) polymerase-1. PLoS ONE 8: e70333.
76. Ota, H., M. Akishita, M. Eto, K. Iijima, M. Kaneki, and Y. Ouchi. 2007. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. Journal of Molecular and Cellular Cardiology 43: 571-579.
77. Paschalaki, K.E., R.D. Starke, Y. Hu, N. Mercado, A. Margariti, V.G. Gorgoulis, A.M. Randi, and P.J. Barnes. 2013. Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence. Stem Cells 31: 2813-2826.
78. Peng, C., Lu, Z., Xie, Z., Cheng, Z., Chen, Y., Tan, M., Luo, H., Zhang, Y., He, W., Yang, K., Zwaans, B.M., Tishkoff, D., Ho, L., Lombard, D., He, T.C., Dai, J., Verdin, E., Ye, Y., and Y. Zhao. 2011. The first identification of lysine malonylation substrates and its regulatory enzyme. Molecular of Cell Proteomics. 10: M111.012658.
79. Pulliero, A., A. Seydel, A. Camoirano, S.C. Saccà, M. Sandri, and A. Izzotti. 2014. Oxidative damage and autophagy in the human trabecular meshwork as related with ageing. PLoS ONE 9: e98106.
80. Qian, B.Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L.R. Campion, E.A. Kaiser, L.A. Snyder, and J.W. Pollard. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225.
81. Rahman, I., and W. MacNee. 1998. Role of transcription factors in inflammatory lung diseases. Thorax 53: 601-612.
82. Rajendrasozhan, S., S.R. Yang, V.L. Kinnula, and I. Rahman. 2008. SIRT1, an antiinflammatory and antiaging protein, is decreased in lungs of patients with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 177: 861-870.
83. Saetta, M., M. Mariani, P. Panina-Bordignon, G. Turato, C. Buonsanti, S. Baraldo, C.M. Bellettato, A. Papi, L. Corbetta, R. Zuin, F. Sinigaglia, and L.M. Fabbri. 2002. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 165: 1404-1409.
84. Sauve, A.A., C. Wolberger, V.L. Schramm, and J.D. Boeke. 2006. The biochemistry of sirtuins. Annual Review of Biochemistry 75: 435-465.
85. +-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes and Development 21: 920-928.
86. Schlereth, K., J.P. Charles, A.C. Bretz, and T. Stiewe. 2010. Life or death: 53-induced apoptosis requires DNA binding cooperativity. Cell Cycle 9: 4068-4076.
87. Schug, T.T., Q. Xu, H. Gao, A. Peres-da-Silva, D.W. Draper, M.B. Fessler, A. Purushotham, and X. Li. 2010. Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Molecular and Cellular Biology 30: 4712-4721.
88. Schwer, B., and E. Verdin. 2008. Conserved metabolic regulatory functions of sirtuins. Cell Metabolism 7: 104-112.
89. Shi, J., N. Yin, L.L. Xuan, C.S. Yao, A.M. Meng, and Q. Hou. 2012. Vam3, a derivative of resveratrol, attenuates cigarette smoke-induced autophagy. Acta Pharmacologica Sinica 33: 888-896.
90. Shi, Y., G.G. Camici, and T.F. Lüscher. 2010. Cardiovascular determinants of life span. Pflugers Archiv European Journal of Physiology 459: 315-324.
91. Shifren, A., and R.P. Mecham. 2006. The stumbling block in lung repair of emphysema: Elastic fiber assembly. Proceedings of the American Thoracic Society 3: 428-433.
92. Siedlinski, M., J.M. Boer, H.A. Smit, D.S. Postma, and H.M. Boezen. 2012. Dietary factors and lung function in the general population: Wine and resveratrol intake. European Respiratory Journal 39: 385-391.
93. Sime, P.J., Z. Xing, F.L. Graham, K.G. Csaky, and J. Gauldie. 1997. Adenovector-mediated gene transfer of active transforming growth factor-β 1 induces prolonged severe fibrosis in rat lung. Journal of Clinical Investigation 100: 768-776.
94. Sommerhoff, C.P., J.A. Nadel, C.B. Basbaum, and G.H. Caughey. 1990. Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. Journal of Clinical Investigation 85: 682-689.
95. - mice. Aging 2: 353-360.
96. Takasaka, N., J. Araya, H. Hara, S. Ito, K. Kobayashi, Y. Kurita, H. Wakui, Y. Yoshii, Y. Yumino, S. Fujii, S. Minagawa, C. Tsurushige, J. Kojima, T. Numata, K. Shimizu, M. Kawaishi, Y. Kaneko, N. Kamiya, J. Hirano, M. Odaka, T. Morikawa, S.L. Nishimura, K. Nakayama, and K. Kuwano. 2014. Autophagy induction by SIRT6 through attenuation of insulin-like growth factor signaling is involved in the regulation of human bronchial epithelial cell senescence. Journal of Immunology 192: 958-968.
97. Takeyama, K., C. Agusti, I. Ueki, J. Lausier, L.O. Cardell, and J.A. Nadel. 1998. Neutrophil-dependent goblet cell degranulation: role of membrane-bound elastase and adhesion molecules. American Journal of Physiology 275: L294-L302.
98. Takizawa, H., M. Tanaka, K. Takami, T. Ohtoshi, K. Ito, M. Satoh, Y. Okada, F. Yamasawa, K. Nakahara, and A. Umeda. 2001. Increased expression of transforming growth factor-beta 1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD). American Journal of Respiratory and Critical Care Medicine 163: 1476-1483.
99. Tang, Y., J. Xu, W. Qu, X. Peng, P. Xin, X. Yang, C. Ying, X. Sun, and L. Hao. 2012. Resveratrol reduces vascular cell senescence through attenuation of oxidative stress by SIRT1/NADPH oxidase-dependent mechanisms. Journal of Nutritional Biochemistry 23: 1410-1416.
100. Tanner, K.G., J. Landry, R. Sternglanz, and J.M. Denu. 2000. Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proceedings of the National Academy of Sciences USA 97: 14178-14182.
101. +-dependent histone deacetylase SIRT1. Journal of Biological Chemistry 282: 6823-6832.
102. Tennen, R.I., E. Berber, and K.F. Chua. 2010. Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mechanisms of Ageing and Development 131: 185-192.
103. Traves, S.L., S.J. Smith, P.J. Barnes, and L.E. Donnelly. 2004. Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: A role for CXCR2. Journal of Leukocyte Biology 76: 441-450.
104. Tsuji, T., K. Aoshiba, and A. Nagai. 2010. Alveolar cell senescence exacerbates pulmonary inflammation in patients with chronic obstructive pulmonary disease. Respiration 80: 59-70.
105. Vakhrusheva, O., C. Smolka, P. Gajawada, S. Kostin, T. Boettger, T. Kubin, T. Braun, and E. Bober. 2008. Sirt7 increases stress resistance of cardiomyocytes and prevents apoptosis and inflammatory cardiomyopathy in mice. Circulation Research 102: 703-710.
106. Verdin, E., M.D. Hirschey, L.W. Finley, and M.C. Haigis. 2010. Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling. Trends in Biochemical Sciences 35: 669-675.
107. Wang, F., M. Nguyen, F.X. Qin, and Q. Tong. 2007. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 6: 505-514.
108. Wang, J.C., and M. Bennett. 2012. Aging and atherosclerosis: Mechanisms, functional consequences, and potential therapeutics for cellular senescence. Circulation Research 111: 245-259.
109. Wilson, M.S., S.K. Madala, T.R. Ramalingam, B.R. Gochuico, I.O. Rosas, A.W. Cheever, and T.A. Wynn. 2010. Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. Journal of Experimental Medicine 207: 535-552.
110. World Health Organization. The 10 leading causes of death in the world, 2000 and 2012. http://who.int/mediacentre/factsheets/fs310/en/. Accessed 15 July 2014.
111. Xu, B., H. Chen, W. Xu, W. Zhang, S. Buckley, S.G. Zheng, D. Warburton, M. Kolb, J. Gauldie, and W. Shi. 2012. Molecular mechanisms of MMP9 overexpression and its role in emphysema pathogenesis of Smad3-deficient mice. American Journal of Physiology Lung Cellular and Molecular Physiology 303: L89-L96.
112. Yadav, U.C., and K.V. Ramana. 2013. Regulation of NF-κB-induced inflammatory signaling by lipid peroxidation-derived aldehydes. Oxidative Medicine Cellular Longevity 2013: 690545.
113. Yang, S.R., J. Wright, M. Bauter, K. Seweryniak, A. Kode, and I. Rahman. 2007. Sirtuin regulates cigarette smoke-induced proinflammatory mediator release via RelA/p65 NF-kappaB in macrophages in vitro and in rat lungs in vivo: Implications for chronic inflammation and aging. American Journal of Physiology Lung Cellular of Molecular 292: L567-L576.
114. Yao, H., and I. Rahman. 2011. Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease. Toxicology and Applied Pharmacology 254: 72-85.
115. Yao, H., S. Chung, J.W. Hwang, S. Rajendrasozhan, I.K. Sundar, D.A. Dean, M.W. McBurney, L. Guarente, W. Gu, M. Rönty, V.L. Kinnula, and I. Rahman. 2012. SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. Journal of Clinical Investigation 122: 2032-2045.
116. Yao, H., J.W. Hwang, I.K. Sundar, A.E. Friedman, M.W. McBurney, L. Guarente, W. Gu, V.L. Kinnula, and I. Rahman. 2013. SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD. American Journal of Physiology Lung Cellular and Molecular Physiology 305: L615-L624.
117. Yeung, F., J.E. Hoberg, C.S. Ramsey, M.D. Keller, D.R. Jones, R.A. Frye, and M.W. Mayo. 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO Journal 23: 2369-2380.
118. Yoshizaki, T., S. Schenk, T. Imamura, J.L. Babendure, N. Sonoda, E.J. Bae, D.Y. Oh, M. Lu, J.C. Milne, C. Westphal, G. Bandyopadhyay, and J.M. Olefsky. 2010. SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. American Journal of Physiology-Endocrinology and Metabolism 298: E419-E428.
119. Yuan, Z., X. Zhang, N. Sengupta, W.S. Lane, and E. Seto. 2007. SIRT1 regulates the function of the Nijmegen breakage syndrome protein. Molecular Cell 27: 149-162.
120. Zheng, T., Z. Zhu, Z. Wang, R.J. Homer, B. Ma, R.J. Riese Jr, H.A. Chapman Jr, S.D. Shapiro, and J.A. Elias. 2000. Inducible targeting of IL-13 to the adult lung causes matrix metalloproteinase- and cathepsin-dependent emphysema. Journal of Clinical Investigation 106: 1081-1093.
121. Zieman, S.J., V. Melenovsky, and D.A. Kass. 2005. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arteriosclerosis Thrombosis and Vascular Biology 25: 932-943.